TGFBR2 and hepatocellular carcinoma: The hepatic expression of Snail-1 was found to be significantly higher in cirrhotic patients with HCC compared to those without HCC (4(3–6) vs. 2(1–3), p<0.001) and control group (4(3–6) vs. 1(1–2), p<0.001), whereas cirrhotic patients with HCC had significantly lower hepatic expression of TGFBR2 than did cirrhotic patients without HCC (2.5(2–4) vs. 4(3–6), p = 0.046) and healthy controls (2.5(2–4) vs. 6(3–9), p = 0.019) (c.f., Table 2).